HEALTHCARE LIFE SCIENCES & REVIEW PHARMACEUTICALS: CARVING INTERVIEW OUT A MEDICAL WITH : CONVERGENCE IN ACTION: SHAKING UP THE SYSTEM RAULDEVICE MANLAPIG, MARKET CASE STUDY: SILANES FOCUSINTERVIEW ON DIABETES WITH: LIFESTYLE MATTERS:PAGE 21 PRINCIPAL MANAGINGPAGE 56 FOCUSPAGE 70 ON: DR. ENRIQUEPAGE T. ONA,82 DIABETES & ONCOLOGY DIRECTOR, ARUP A BOOM IN BPO SECRETARY OF HEALTH PAGE 12 PAGE 30 PAGE 20 PAGE 34 MEXICO 2013 COFEPRIS Revamped Mikel Arriola, the man who changed an institution and an industry PAGE 18 published in association with PHILHEALTH: A PRIORITY FOR THE AQUINO ADMINISTATION. PAGE 7 PHILIPPINES2013 March 2014 2 In a world of constant change, we stretch beyond the limits The healthcare information management (HIM) industry is changing rapidly. From new technologies that open up possibilities for bringing services closer to people to a complete overhaul of how health issues are reported and diagnosed, the old ways of providing healthcare are quickly becoming obsolete. Pointwest backs up its long experience in HIM with its highly-skilled and agile IT staff to make sure you keep up with the changes, especially as the industry gets a major overhaul with the shift to ICD 10 and its effect on the IT infrastructure of HIM providers. The shape of healthcare is changing. With Pointwest as your HIM partner, you’ll be assured that you will stay fit, no matter what shape the industry becomes. Head Office 12th Floor Citibank Center 8741 Paseo de Roxas Contact Person: Makati City 1226, Philippines Renato B. Quizon Executive Director Business Development Website: www.pointwest.com.ph [email protected] Facebook: www.facebook.com/Pointwest.PH Mobile: +63917 861 0345 Twitter:PHILIPPINES @PointwestPH MARCH. 2014 Phone: +632 814 1102 3 Acknowledgements Pharmaboardroom would like to thank Dr. Enrique T. Ona, Secretary of Health, Mr. Alexander Padilla, President and CEO of PhilHealth, Mr. Kenneth Hartigan-Go, acting Director FDA Philippines, Teodoro B. Padilla, Executive Director and Reiner W. Gloor, Adviser, Pharmaceutical and Healthcare Association of the In a world of constant change, Philippines (PHAP) and Thelma Tobias–Go, we stretch beyond the limits President, The Philippine Chamber of the Pharmaceutical Industry (PCPI) for their The healthcare information management (HIM) industry is changing rapidly. From new contributions to this report. technologies that open up possibilities for bringing services closer to people to a complete overhaul of how health issues are reported and diagnosed, the old ways of providing healthcare are quickly becoming obsolete. Pointwest backs up its long experience in HIM with its highly-skilled and agile IT staff to make sure you keep up with the changes, especially as the industry gets a major overhaul with the shift to ICD 10 and its effect on the IT infrastructure of HIM providers. The shape of healthcare is changing. With Pointwest as your HIM partner, you’ll be assured that you will stay fit, no matter what shape the industry becomes. Head Office 12th Floor Citibank Center 8741 Paseo de Roxas Contact Person: Makati City 1226, Philippines Renato B. Quizon Executive Director Business Development Website: www.pointwest.com.ph [email protected] Facebook: www.facebook.com/Pointwest.PH Mobile: +63917 861 0345 Twitter: @PointwestPH Phone: +632 814 1102 PHILIPPINES MARCH. 2014 5 CONTENTS 7 CONNECTING THE DOTS 8 QUANTIFYING THE MARKET 9 HIGH STAKES FOR NEW STAKEHOLDERS 9 MATURE NEIGHBOR DOWN UNDER 10 RELEVANCE: TO BE OR NOT TO BE? 11 CORPORATE CALLING 12 LIFESTYLE MATTERS 13 MABUHAY! NAMASTE! 14 WHAT’S RITE IN A NAME 14 SALES 2 MANUFACTURING 16 EN PRISE! 17 THE RE-TALE: A STORY OF GENERICS 18 MORE GOVERNMENT, MORE PRIVATE 19 PIONEERING HARMONY 20 A BOOM IN BPO INTERVIEWS 24 Interview with: Gregorio Navarro, Managing Partner & Ceo, Deloitte Philippines 27 Interview with: Maria Cristina G. ‘Beng’ Coronel, President, Pointwest Technologies 30 Interview with: Raul Manlapig, Principal Managing Director, Arup, Philippines 32 Interview with: Jason Carroll, General Manager, Janssen (Philippines) 34 Interview with: Dr. Enrique T. Ona, Secretary Of Health, Department Of Health 36 Interview with: Alexander A. Padilla, President & Ceo, Philhealth 38 Interview with: Dr. Kenneth Y Hartigan-Go, General Director, Fda 40 Interview with: Teodoro B. Padilla & Reiner W. Gloor, Executive Director & Advisor, Phap 41 Interview with: Thelma Tobias-Go And Ed Ocampo, President Of Pcpi & Vp Of Scheele Laboratories 42 Interview with: Thomas Weigold, Country President And Managing Director, Novartis 44 Interview with: Juanito Luna, Founding President And Ceo, Prosel 46 Interview with: A.A. Santillana, Group Chairman & Ceo, Sv More, Philippines This report was prepared by Pharmaboardroom.com Project Director: Koen Liekens Project Coordinators: Alina Manac, Ibtissam Sadouni Project Publishers: Julie Avena Contributors: Teddy Lamazere Graphic Assistance: Omar Rahli, Nisha Albuquerque Copyright All rights reserved. No part of this publication maybe reproduced in any form or by any means, whether electronic, mechanical or otherwise including photocopying, recording or any information storage or retrieval system without prior written consent of Focus Reports. While every attempt is made to ensure the accuracy of the information contained in this report, neither Focus Reports nor the authors accept any liabilities for errors and omissions. Opinions expressed in this report are not necessarily those of the authors. PHILIPPINES MARCH. 2014 6 PHILIPPINES MARCH. 2014 magentablackcyanyellow SV More Group FP APPROVED_1-1.pgs 01.17.2014 18:58 ADVANSTAR_PDF/X-1a 7 Pharmaboardroom.com SPECIAL SPONSORED SECTION Philippines Report Harvest, by Adrian Morales. Credit Julita Geronimo, Globo PHILIPHILIPPPPINES:INES: Asiatico Enterprises Inc. Connecting the Dots he inclusion of healthcare as a priority on the This sponsored supplement presidential agenda has led to knock-on conse- was produced by Focus Reports. quences that are being felt across the healthcare Project Director: Koen Liekens value chain in the Philippines. Universal health- Project Coordinators: Alina Manac, T Ibtissam Sadouni care coverage (UHC) has been cemented, which has Project Publishers: Julie Avena led to a shift from branded medicines to generics, Contributors: Teddy Lamazere leading many players to a strategic repositioning. The Graphic Assistance: Omar Rahli, most successful players have been those who focused Nisha Albuquerque on a strategy that was inclusive of all stakeholders For exclusive interviews and more info, please and aligned with the presidential agenda of affordable log onto www.pharmaboardroom.com and accessible healthcare. or write to [email protected] PHILIPPINES MARCH. 2014 FEBRUARY 2014 FOCUS REPORTS S2 Pharmaboardroom.com 8 SPECIAL SPONSORED SECTION Philippines Report “When the new administration took rolled 83 percent of the population. “The over in 2010, our mantra was to include the enrolment rate means that these are people previously overlooked poorest segment of that have come under the health insurance the population,” says Enrique Ona, secre- program at one point or another. Whether tary of health of the Philippines. “Through they can avail of benefi ts is what our cov- our Department of Social Welfare, we had erage rate focuses on. Our covered rate is identifi ed 5.2 million households -which really around 73 to 74 percent,” explains could include four to fi ve family mem- Alexander Padilla, president and CEO of bers- as part of the poor layer of society. In From left: Dr. Enrique T. Ona, secretary of PhilHealth. “Our key priorities remain terms of people, that number comes down health; Alexander Padilla, president and membership and benefi ts. In line with the CEO of PhilHealth to roughly 25 million, or a quarter of the country’s population,” said Ona. Now, the challenge of the Department of Health (DOH) is to address the next layer of society, the so-called ‘near poor’ that are not yet en- Quantifying the market rolled in the PhilHealth scheme. “The projected number of fami- lies from this layer is 14.7 million, essentially 58.8 million Filipi- In IMS Health vocabulary, the Philippines would count as a ‘Frontier Market’. Along with Malaysia and nos, that should be enrolled by the end of 2014,” Ona explains. Bangladesh, these markets are expected to each Since 2010, the Aquino administration has reached a num- have a sales increase of USD 2.7 billion by 2017. ber of major achievements on the healthcare front. The amend- For the Philippines, this would mean an approximate ment to the National Health Insurance Act, offi cially called doubling in value. Nonetheless, the Philippines ben- Republic Act 10606, was essential in the sense that it made it efi ts from the strong momentum of the many mar- mandatory for all Filipinos to be covered through the national kets in the Asia-Pacifi c region, driven in large part insurance body PhilHealth. Offi cially, PhilHealth now has en- by macroeconomic growth, rising healthcare spend, and urbanization. Based on the IMS market progno- sis, the CAGR of the Philippines will average around 3.8 percent to 4 percent through 2017, up from the current three percent. Among the factors that are expected to fuel this growth are improvements in healthcare facilities across the country, the contin- ued push for generic medicines and for generics- only pharmacies, and the eventual implementation of UHC, according to IMS Health. Philippines Total Annual Sales Value (ExMNF USD) US$ Bn 3,500 Branded Generics Unbranded Generics Originator Generics Other 3,000 2,703 2,585 2,449 2,515 2,500 2,212 2,019 51.2% 2,000 47.8% 49.3% 49.9% 46.8% 1,500 45.8% 1,000 41.2% 38.4% 37% 35.9% 43.8% 42.6% 500 0 2006 2007 2008 2009 2010 2011(f) Source: IMS MIDAS Data, QTR 1 2011, forecast from Market Program 2011-2015 Pharmaceutical sales, USD Bn 2.911 Pharmaceutical sales, USD per capita 31 Pharmaceutical sales, % of health expenditure 34.50 Pharmaceutical exports, USD Mn 43.4 Pharmaceutical imports, USD Mn 777.1 Source: IFPMA, 2012; Business Monitor International 10.